SQZ Biotechnologies Co
SQZDelisted Jul 19, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001604477
SQZ Biotechnologies Co was delisted on Jul 19, 2023; its insiders filed their last Form 4 on Jun 15, 2023; 31 institutions reported holding it in 13F filings for Q2 2023, worth $2.96M in total; Maverick Capital was the only superinvestor holding it.
Q3 2021 vs. Q2 2021
How the institutions holding SQZ Biotechnologies Co changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 49 | 44 | −5 |
| Shares | 13.6M | 13.8M | +249.6K (+1.8%) |
| Value | $195.9M | $199.1M | +$3.21M (+1.6%) |
New holders (2)
Institutions that held SQZ Biotechnologies Co at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| MetLife Investment Management | 9,534 | $137.5K | 0.00% |
| Metropolitan Life Insurance Co | 7,213 | $104.0K | 0.00% |
Sold out (7)
Institutions that held SQZ Biotechnologies Co at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Luminus Management LLC | 353,895 | $5.11M |
| Jacobs Levy Equity Management, Inc | 69,189 | $1.00M |
| Acadian Asset Management LLC | 46,249 | $668.0K |
| Jump Financial, LLC | 26,955 | $389.0K |
| Cubist Systematic Strategies, LLC | 22,524 | $325.0K |
| STRS Ohio | 1,100 | $15.0K |
| Parallel Advisors, LLC | 74 | $1.00K |